Use of antineoplastic agents in patients with cancer who have HIV/AIDS
- PMID: 21570912
- PMCID: PMC3343721
- DOI: 10.1016/S1470-2045(11)70056-0
Use of antineoplastic agents in patients with cancer who have HIV/AIDS
Abstract
Highly active antiretroviral therapy (HAART) has substantially reduced morbidity and mortality of AIDS-related complications in patients with HIV; however, the prevalence of AIDS-defining cancers and non-AIDS-defining cancers has increased. In this Review we discuss the management of HAART pharmacotherapy in relation to cytotoxic chemotherapy or targeted antineoplastic agents. We will review potential pharmacological interactions between antiretroviral and antineoplastic therapies and consider how to combine antiretroviral and antineoplastic agents in patients with HIV who are receiving HAART therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook.Curr Opin Oncol. 2009 Sep;21(5):445-54. doi: 10.1097/CCO.0b013e32832f3e04. Curr Opin Oncol. 2009. PMID: 19606034 Free PMC article. Review.
-
Pharmacotherapy in cancer patients with HIV/AIDS.Clin Pharmacol Ther. 2014 Apr;95(4):370-2. doi: 10.1038/clpt.2014.10. Epub 2014 Jan 17. Clin Pharmacol Ther. 2014. PMID: 24440966 Free PMC article.
-
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors.Invest New Drugs. 2017 Apr;35(2):247-249. doi: 10.1007/s10637-016-0405-0. Epub 2016 Nov 12. Invest New Drugs. 2017. PMID: 27838867
-
The cancer-HIV/AIDS treatment conundrum.J Natl Cancer Inst. 2010 Nov 3;102(21):1615-7. doi: 10.1093/jnci/djq447. Epub 2010 Oct 21. J Natl Cancer Inst. 2010. PMID: 20966428 No abstract available.
-
Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.Pharmacotherapy. 2007 Jan;27(1):122-36. doi: 10.1592/phco.27.1.122. Pharmacotherapy. 2007. PMID: 17192166 Review.
Cited by
-
Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection.Front Pharmacol. 2016 Mar 30;7:71. doi: 10.3389/fphar.2016.00071. eCollection 2016. Front Pharmacol. 2016. PMID: 27065862 Free PMC article. Review.
-
Haemopoietic cell transplantation in patients living with HIV.Lancet HIV. 2020 Sep;7(9):e652-e660. doi: 10.1016/S2352-3018(20)30117-X. Epub 2020 Aug 10. Lancet HIV. 2020. PMID: 32791046 Free PMC article. Review.
-
Human hepatocyte assessment of imatinib drug-drug interactions - complexities in clinical translation.Br J Clin Pharmacol. 2015 Nov;80(5):1097-108. doi: 10.1111/bcp.12723. Epub 2015 Sep 19. Br J Clin Pharmacol. 2015. PMID: 26178713 Free PMC article.
-
A case of esophageal cancer with human immunodeficiency virus infection that progressed rapidly after neoadjuvant chemoradiotherapy.Clin J Gastroenterol. 2020 Feb;13(1):17-21. doi: 10.1007/s12328-019-01028-z. Epub 2019 Jul 27. Clin J Gastroenterol. 2020. PMID: 31352645
-
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.AIDS. 2014 Feb 20;28(4):453-65. doi: 10.1097/QAD.0000000000000071. AIDS. 2014. PMID: 24401642 Free PMC article. Review.
References
-
- Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853–60. - PubMed
-
- Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. Aids. 2007;21(6):685–92. - PubMed
-
- Seden K, Back D, Khoo S. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable. J Antimicrob Chemother. 2009;64(1):5–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical